Aurobindo Pharma’s US Branch Recalls Blood Pressure Medication Over Cancer-Causing Chemical

Aurobindo Pharma USA is voluntarily recalling two lots of blood pressure medication because of high levels of nitrosamine, the U.S. Food and Drug Administration (FDA) said.
The New Jersey-based company initiated the recall of quinapril and hydrochlorothiazide in 20 milligram and 12.5 milligram tablets due to the presence of the chemical, which is associated with a higher risk of cancer. The tablets are used to treat high blood pressure.
“Nitrosamines are common in water and foods, including cured and grilled meats, dairy products, and vegetables. Everyone is exposed to some level of nitrosamines,” according to the FDA. “These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.”…